Document is current
Any future updates will be listed below
-
Authors
Seelbinder, Bastian https://orcid.org/0000-0002-7458-5289
Lohinai, Zoltan
Vazquez-Uribe, Ruben
Brunke, Sascha
Chen, Xiuqiang
Mirhakkak, Mohammad
Lopez-Escalera, Silvia
Dome, Balazs
Megyesfalvi, Zsolt
Berta, Judit
Galffy, Gabriella
Dulka, Edit
Wellejus, Anja
Weiss, Glen J. https://orcid.org/0000-0002-6067-597X
Bauer, Michael https://orcid.org/0000-0002-1521-3514
Hube, Bernhard
Sommer, Morten O. A. https://orcid.org/0000-0003-4005-5674
Panagiotou, Gianni
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft
2018 LCFA-BMS/IASLC Young Investigator Scholarship Award. ZL acknowledge funding from the Hungarian National Research, Development and Innovation Office
Novo Nordisk Fonden (NNF17CO0028232, NNF20CC0035580)
- License Information
-
More Information
Article History
Received: 2 May 2022
Accepted: 11 April 2023
First Online: 9 May 2023
Competing interests
: GJW is a former employee of SOTIO Biotech Inc. and Unum Therapeutics; reports personal fees from Imaging Endpoints II, MiRanostics Consulting, Gossamer Bio, Paradigm, International Genomics Consortium, Angiex, IBEX Medical Analytics, GLG Council, Guidepoint Global, Genomic Health, Oncacare, Rafael Pharmaceuticals, HiRO, and SPARC-all outside this submitted work; has ownership interest in Unum Therapeutics (now Cogent Biosciences), MiRanostics Consulting, Exact Sciences, Moderna, Agenus, Aurinia Pharmaceuticals, and Circulogene-outside the submitted work; and has issued patents: PCT/US2008/072787, PCT/US2010/043777, PCT/US2011/020612, and PCT/US2011/037616-all outside the submitted work. The remaining authors declare they have no competing interests.
